FDA Approves Revtorpyk for Advanced HR-Positive, HER2-Negative Breast CancerByQuincy AttobrahJuly 14th 2026
FDA Approves Trodelvy Alone or With Keytruda for First-Line Triple-Negative Breast CancerByQuincy AttobrahJune 24th 2026